Doxorubicin Market Research Report Information by Application (liver cancer, lung cancer), By Distribution Channel (hospital pharmacy, retail pharmacy) - Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Doxorubicin Market, by Application

6.1 Introduction

6.2 Liver cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Gastric cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Breast cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Bone sarcoma

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Prostate cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7 Stomach Cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.8 Ovarian cancer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.9 Leukemia

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.10 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global DoxorubicinMarket, by Distribution Channel

7.1 Introduction

7.2 Hospital pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Retail pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Doxorubicin Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 Latin America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Pfizer, Inc.

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Sun Pharmaceutical Industries Ltd..

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Janssen Pharmaceuticals

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Accord Healthcare.

10.4.1 Company Overview

10.4.2 Technologys/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Novartis AG.

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Sandoz.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Dr. Reddy’s Laboratories Ltd.

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Teva Pharmaceuticals

10.8.1 Overview

10.8.2 Treatment Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 GLENMARK PHARMACEUTICALS LTD.

10.9.1 Overview

10.9.2 Treatment Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Others.

10.10.1 Overview

10.10.2 Treatment Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

Chapter 11. Appendix

LIST OF TABLES

Table 1 Global Doxorubicin Market Synopsis, 2020-2027

Table 2 Global Doxorubicin Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Doxorubicin Market, by Region, 2020-2027 (USD Million)

Table 4 North America: DoxorubicinMarket, by Application, 2020-2027 (USD

Million)

Table 5 North America: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD

Million)

Table 6 US: Doxorubicin Market, by Application , 2020-2027 (USD Million)

Table 7 US: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD Million)

Table 8 Canada: Doxorubicin Market, by Application, 2020-2027 (USD

Million)

Table 9 Canada: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD

Million)

Table 10 South America: Doxorubicin Market, by Application, 2020-2027 (USD

Million)

Table 11 South America: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD

Million)

Table 12 Europe: Doxorubicin Market, by Application, 2020-2027 (USD Million)

Table 13 Europe: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD Million)

Table 14 Western Europe: Doxorubicin Market, by Application, 2020-2027

(USD Million)

Table 15 Western Europe: Doxorubicin Market, by Distribution Channel, 2020-2027

(USD Million)

Table 16 Eastern Europe: Doxorubicin Market, by Application, 2020-2027

(USD Million)

Table 17 Eastern Europe: Doxorubicin Market, by Distribution Channel, 2020-2027

(USD Million)

Table 18 Asia-Pacific: Doxorubicin Market, by Application, 2020-2027 (USD

Million)

Table 19 Asia-Pacific: Doxorubicin Market, by Distribution Channel, 2020-2027 (USD

Million)

Table 20 Middle East & Africa: Doxorubicin Market, by Application, 2020-2027

(USD Million)

Table 21 Middle East & Africa: Doxorubicin Market, by Distribution Channel, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Doxorubicin Market

Figure 3 Segmentation Market Dynamics for Global Doxorubicin Market

Figure 4 Global Doxorubicin Market Share, by Application, 2020

Figure 5 Global Doxorubicin Market Share, by Distribution Channel, 2020

Figure 6 Global Doxorubicin Market Share, by Region, 2020

Figure 7 North America: Doxorubicin Market Share, by Country, 2020

Figure 8 Europe: Doxorubicin Market Share, by Country, 2020

Figure 9 Asia-Pacific: Doxorubicin Market Share, by Country, 2020

Figure 10 Middle East & Africa: Doxorubicin Market Share, by Country, 2020

Figure 11 Global Doxorubicin Market: Company Share Analysis, 2020 (%)

Figure 12 Pfizer, Inc: Key Financials

Figure 13 Pfizer, Inc: Segmental Revenue

Figure 14 Pfizer, Inc: Geographical Revenue

Figure 15 Sun Pharmaceutical Industries Ltd.: Key Financials

Figure 16 Sun Pharmaceutical Industries Ltd.: Segmental Revenue

Figure 17 Sun Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 18 Janssen Pharmaceuticals: Key Financials

Figure 19 Janssen Pharmaceuticals: Segmental Revenue

Figure 20 Janssen Pharmaceuticals: Geographical Revenue

Figure 21 Accord Healthcare.: Key Financials

Figure 22 Accord Healthcare.: Segmental Revenue

Figure 23 Accord Healthcare.: Geographical Revenue

Figure 24 Novartis AG

Figure 25 Sandoz

Figure 26 Dr. Reddy’s Laboratories Ltd.

Figure 27 Teva Pharmaceuticals

Figure 28 GLENMARK PHARMACEUTICALS LTD